Painkillers in higher doses, taken over longer periods for chronic pain increase overdose risk
the ONA take:
According to a new study published in The Journal of Pain, researchers from the School of Medicine at the University of Texas have found that painkillers in higher doses and taken over longer periods for chronic pain increase the risk of overdose.
For the study, researchers developed a database to analyze medications, health care delivery, and comorbid conditions for over 200,000 HMO-enrolled patients who filled two or more prescriptions for opioids for non-cancer pain between 2009 and 2012. Results showed that a morphine equivalent total daily dose of 100mg or more significantly increased the risk of drug overdose.
In addition, patients who took 50-99mg/day were at an increased risk of drug overdose if they filled prescriptions totaling the morphine equivalent of at least 1,830mg over a 6-month period.
A second study published in The Journal of General Internal Medicine found that the risk of drug overdose is multiplicative if they are taking benzodiazepines on top of opioids.
The findings suggest that healthcare providers should be mindful of the drug combination that they are prescribing as well as how much opioids they have prescribed a patients over a period of time.
Painkillers in higher doses and taken over longer periods for chronic pain increase the risk of overdose.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|